Abstract
“JALA10 nominations are due by April 1, 2011.”
Emerging technologies and methodologies that serve as the foundation for discovery with increased efficiency and accuracy represent the lifeblood of the SLAS membership. Our scientific community and its resources are expanding at a remarkable rate, and even the most fundamental of changes are being harnessed to achieve translationally significant advancements by laboratory automation professionals.
This year, we will again honor work that has made seminal impact toward the study of key biological and medical quandaries by selecting a new class of “The JALA10.” This special feature will highlight the top 10 technological breakthroughs across a spectrum of fields that include, but are not limited to laboratory automation, drug discovery, drug screening, novel therapeutic strategies and delivery technologies, diagnostics, nanotechnology, nanomedicine, microtechnology as it relates to biology and medicine, novel characterization techniques, and more.
Nominations are open to anyone and everyone (i.e., SLAS members and nonmembers alike). A JALA10 Selection Committee comprising members of the JALA Editorial Board and other professionals from the broader science and engineering community with representation from the academic, commercial, and government sectors will evaluate all nominations received. The committee will specifically search for work that has generated profound impact on the general fields of biology and medicine. Fundamental and applied breakthroughs are eligible, and all fields of innovation with specific relevance toward biology and medicine will be considered.
Nominations are due by April 1, 2011, and must include:
A concise, 100-word description of the work and a representative color image. If selected, the description and image will be published in JALA. To assist the JALA10 Selection Committee, nominators also must provide a 500-word detailed report of why the nominated work merits selection to the JALA10. To be eligible for the JALA10, the nominated work must have been reported in a peer-reviewed publication to ensure that technical merit has been evaluated via blind refereeing (online is acceptable). Publication information must be provided.
We hope you will participate in this exciting program as we recognize the discoveries that are forging a bright future for the bio/medical research community. For more information, please visit www.SLAS.org.
Sincerely,
